Cargando…

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus

Objectives. SLE is a systemic autoimmune disease with an annual incidence of 3.8 per 100 000. Several pathogenic mechanisms are believed to be operating in SLE, including an impaired clearance of apoptotic cells, activation of the type I IFN pathway and generation of autoimmune leucocytes. Growth ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekman, Carl, Jönsen, Andreas, Sturfelt, Gunnar, Bengtsson, Anders A., Dahlbäck, Björn
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093930/ https://www.ncbi.nlm.nih.gov/pubmed/21278074 http://dx.doi.org/10.1093/rheumatology/keq459

Ejemplares similares

Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
por: Ekman, Carl, et al.
Publicado: (2010)

Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
por: Wu, Jun, et al.
Publicado: (2011)

Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2019)

Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
por: Apostolo, Daria, et al.
Publicado: (2023)

Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus
por: Ballantine, Lucy, et al.
Publicado: (2015)

Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System on Platelets in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2014)

Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility
por: Jönsen, Andreas, et al.
Publicado: (2004)

Prognostic value of plasma sAXL in patients with heart failure: insights from the DRAGON‐HF trial
por: Liu, Yifan, et al.
Publicado: (2022)

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
por: Sjöwall, Christopher, et al.
Publicado: (2004)

Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients
por: Jaksch-Bogensperger, Heidi, et al.
Publicado: (2018)

Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus
por: Zervides, Kristoffer A., et al.
Publicado: (2022)

Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays
por: Carlsson, Anders, et al.
Publicado: (2011)

Elevated Levels of Soluble Axl (sAxl) Regulates Key Angiogenic Molecules to Induce Placental Endothelial Dysfunction and a Preeclampsia-Like Phenotype
por: Gui, Shunping, et al.
Publicado: (2021)

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
por: Martin, Myriam, et al.
Publicado: (2017)

The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
por: Compagno, Michele, et al.
Publicado: (2016)

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
por: Leonard, Dag, et al.
Publicado: (2018)

Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study
por: Brosseron, Frederic, et al.
Publicado: (2023)

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
por: Imgenberg-Kreuz, Juliana, et al.
Publicado: (2018)

Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus
por: Jönsen, Andreas, et al.
Publicado: (2011)

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
por: Gustafsson, Anna, et al.
Publicado: (2009)

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren’s Syndrome and Systemic Sclerosis
por: Bengtsson, Anders A., et al.
Publicado: (2016)

Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study
por: Zervides, Kristoffer A., et al.
Publicado: (2022)

Sex differences in clinical presentation of systemic lupus erythematosus
por: Ramírez Sepúlveda, Jorge I., et al.
Publicado: (2019)

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
por: Sigurdsson, Snaevar, et al.
Publicado: (2008)

Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
por: Linge, Carl Petrus, et al.
Publicado: (2022)

Serum Midkine Levels in Systemic Lupus Erythematosus
por: Marpaung, Blondina, et al.
Publicado: (2018)

Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus
por: Leffler, Jonatan, et al.
Publicado: (2013)

Low Intra-Individual Variation in Mean Platelet Volume Over Time in Systemic Lupus Erythematosus
por: Wirestam, Lina, et al.
Publicado: (2021)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
por: Parodis, Ioannis, et al.
Publicado: (2020)

Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
por: Lood, Christian, et al.
Publicado: (2011)

Contributions of de novo variants to systemic lupus erythematosus
por: Almlöf, Jonas Carlsson, et al.
Publicado: (2020)

Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus: An Observational Study from a Single Centre in Sweden
por: Saleh, Muna, et al.
Publicado: (2020)

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity
por: Thornhill, Susannah I., et al.
Publicado: (2017)

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2017)

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
por: Alexander, Tobias, et al.
Publicado: (2015)

MRI BrainAGE demonstrates increased brain aging in systemic lupus erythematosus patients
por: Kuchcinski, Grégory, et al.
Publicado: (2023)

Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2015)

Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus
por: Kato, Yasuhiro, et al.
Publicado: (2018)

Autophagy is activated in systemic lupus erythematosus and required for plasmablast development
por: Clarke, Alexander J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hqcnio3iui2gbak9btl7v9ii0l